According to a Bloomberg journalist and long time Apple tracker Mark Gurman in his recent newsletter tipped that, Apple’s first conference will be held in March or April this year, which is the same time in previous years. It’s the time of Apple’s spring new product launch, and there is already news about the new products at the launch. The iPhone SE 3 and the newly designed MacBook Air will be the focus of this launch and the conference is still online and virtual.
The appearance of the third-generation iPhone SE to be released this time will not change much, with a design similar to the iPhone 8, which means that the appearance of the iPhone SE 3 phone will be more similar to the iPhone SE 2. The highlight of the main upgrade is the upgrade of hardware configuration and support for 5G Internet access. The iPhone SE 3 will be powered by a Bionic A15 processor, built with a 5nm+ process, and a plug-in 5G Internet baseband. Various reports are floating on the internet about the price of the iPhone SE 3. The report suggests that the price of the iPhone SE 3 is less than $400, which is even cheaper than the price of the iPhone SE 2. Keeping prices low may aim to attract low-end Android users to switch.
Apart from the iPhone, there is another product which will be MacBook Air 2022 and Apple will completely redesign the MacBook Air for 2022. Apple has launched a variety of colors to choose from on the new iPad Air, iMac and HomePod mini, and now the multi-colour design style is also coming to the new MacBook Air, which is different from the performance-oriented Pro version. It is reported that the new MacBook Air will use the M2 chip, and the single-core performance has been improved. But limited to the positioning of the MacBook Air, its overall performance will not exceed the released MacBook Pro equipped with M1Pro and M1 Max.
At WWDC in June, Apple will unveil the next generation of operating systems, including iOS 16 (codenamed SYDNEY), TvOS 16 (codenamed PARIS), macOS 13 (codenamed ROME) and watchOS 9 (codenamed KINCAID).